WO2008155619A3 - Preparation of optically-active cyclic amino acids - Google Patents
Preparation of optically-active cyclic amino acids Download PDFInfo
- Publication number
- WO2008155619A3 WO2008155619A3 PCT/IB2008/001556 IB2008001556W WO2008155619A3 WO 2008155619 A3 WO2008155619 A3 WO 2008155619A3 IB 2008001556 W IB2008001556 W IB 2008001556W WO 2008155619 A3 WO2008155619 A3 WO 2008155619A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- optically
- preparation
- amino acids
- cyclic amino
- formula
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C255/00—Carboxylic acid nitriles
- C07C255/45—Carboxylic acid nitriles having cyano groups bound to carbon atoms of rings other than six-membered aromatic rings
- C07C255/46—Carboxylic acid nitriles having cyano groups bound to carbon atoms of rings other than six-membered aromatic rings to carbon atoms of non-condensed rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C227/00—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C227/30—Preparation of optical isomers
- C07C227/32—Preparation of optical isomers by stereospecific synthesis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C229/28—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being saturated and containing rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/56—Ring systems containing three or more rings
- C07D209/96—Spiro-condensed ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/07—Optical isomers
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/06—Systems containing only non-condensed rings with a five-membered ring
- C07C2601/08—Systems containing only non-condensed rings with a five-membered ring the ring being saturated
Abstract
Methods and materials for preparing an optically active compound of Formula (1), or a pharmaceutically acceptable salt thereof, or an opposite enantiomer of the compound of Formula (1) or pharmaceutically acceptable salt thereof, are disclosed. The method includes reducing a cyano moiety of a compound of Formula (5), or an opposite enantiomer thereof, or a salt of the compound of Formula (5) or opposite enantiomer thereof, to an amino moiety, wherein R1, R2, and R5 are defined in the specification.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US94558407P | 2007-06-21 | 2007-06-21 | |
US60/945,584 | 2007-06-21 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2008155619A2 WO2008155619A2 (en) | 2008-12-24 |
WO2008155619A3 true WO2008155619A3 (en) | 2009-08-13 |
Family
ID=40101023
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/IB2008/001556 WO2008155619A2 (en) | 2007-06-21 | 2008-06-09 | Preparation of optically-active cyclic amino acids |
Country Status (4)
Country | Link |
---|---|
JP (1) | JP2009108024A (en) |
AR (1) | AR069268A1 (en) |
TW (1) | TW200906770A (en) |
WO (1) | WO2008155619A2 (en) |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1999021824A1 (en) * | 1997-10-27 | 1999-05-06 | Warner-Lambert Company | Cyclic amino acids and derivatives thereof useful as pharmaceutical agents |
WO1999031075A1 (en) * | 1997-12-16 | 1999-06-24 | Warner-Lambert Company | 1-substituted-1-aminomethyl-cycloalkane derivatives (=gabapentin analogues), their preparation and their use in the treatment of neurological disorders |
WO2001042191A1 (en) * | 1999-12-08 | 2001-06-14 | Warner-Lambert Company | Branched chain amino acid-dependent aminotransferase inhibitors and their use in the treatment of diabetic retinopathy |
-
2008
- 2008-06-09 WO PCT/IB2008/001556 patent/WO2008155619A2/en active Application Filing
- 2008-06-18 JP JP2008158803A patent/JP2009108024A/en active Pending
- 2008-06-20 AR ARP080102671A patent/AR069268A1/en unknown
- 2008-06-20 TW TW097123073A patent/TW200906770A/en unknown
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1999021824A1 (en) * | 1997-10-27 | 1999-05-06 | Warner-Lambert Company | Cyclic amino acids and derivatives thereof useful as pharmaceutical agents |
WO1999031075A1 (en) * | 1997-12-16 | 1999-06-24 | Warner-Lambert Company | 1-substituted-1-aminomethyl-cycloalkane derivatives (=gabapentin analogues), their preparation and their use in the treatment of neurological disorders |
WO2001042191A1 (en) * | 1999-12-08 | 2001-06-14 | Warner-Lambert Company | Branched chain amino acid-dependent aminotransferase inhibitors and their use in the treatment of diabetic retinopathy |
Non-Patent Citations (1)
Title |
---|
GARETH GRIFFITHS ET AL: "Novel Syntheses of Gabapentin via Addition of Hydrocyanic Acid to Cyclohexylidenemalonate or Cyano(cyclohexylidene)acetate", HELVETICA CHIMICA ACTA, VERLAG HELVETICA CHIMICA ACTA. BASEL, CH, vol. 74, no. 2, 1 January 1991 (1991-01-01), pages 309 - 314, XP002100736, ISSN: 0018-019X * |
Also Published As
Publication number | Publication date |
---|---|
AR069268A1 (en) | 2010-01-13 |
TW200906770A (en) | 2009-02-16 |
WO2008155619A2 (en) | 2008-12-24 |
JP2009108024A (en) | 2009-05-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2007048064A3 (en) | Amino-pyrimidines as casein kinase ii (ck2) modulators | |
IL196779A0 (en) | Process for the preparation of optically active chiral amines | |
WO2009018065A3 (en) | Novel glucokinase activators and methods of using same | |
WO2009141718A3 (en) | Process for the preparation of prostaglandin analogues and intermediates thereof | |
MY158073A (en) | Process for producing optically active amine derivatives | |
WO2006094974A3 (en) | Chemically defined stabiliser composition | |
WO2011054436A3 (en) | Halogenalkyl-substituted amides used as insecticides and acaricides | |
WO2011038185A3 (en) | Methods for preparing pyrimidine derivatives useful as protein kinase inhibitors | |
WO2007119114A3 (en) | Improved synthesis and preparations of duloxetine salts | |
WO2009100936A3 (en) | Novel aromatic fluoroglycoside derivatives, pharmaceuticals comprising said compounds, and the use thereof | |
WO2008136393A1 (en) | Crystal of lactam compound, and method for production thereof | |
WO2007099171A3 (en) | Bicyclo-pyrazoles active as kinase inhibitors | |
TW200612959A (en) | Method for preparing hydroxamic acids | |
EA201071120A1 (en) | METHOD OF OBTAINING HETEROARILBENZE DERIVATIVES OF SULFAMATES AND CRYSTALLINE FORM N - ((2S) -6-CHLOR-2,3-DIGYDRO-L, 4-BENZODIOXIN-2-IL) METHYL SULFAMIDE | |
IL183163A0 (en) | Sulfonamido-macrocycles as tie2 inhibitors and the salts thereof, a pharmaceutical composition comprising these compounds, the method of preparing and the use thereof | |
WO2009095624A3 (en) | Method for preparing dicaffeoylquinic acids and use thereof in combating aphids | |
WO2008092939A3 (en) | Process for the preparation of optically pure omeprazole via salt formation with a chiral amine or treatment with an entiomer converting enzyme and chromatographic separation | |
TW200714584A (en) | Method of preparation of maob inhibitors | |
HK1133001A1 (en) | Novel method for producing 4,4'-(1-methyl-1,2-ethanediyl)-bis-(2,6- piperazinedione) | |
WO2009047634A3 (en) | Aqueous formulations of acetaminophen for injection | |
WO2011135586A3 (en) | Process for the preparation of chiral beta amino carboxamide derivatives | |
PL2371820T3 (en) | Optically active cyclic alcohol compound and method for preparing the same | |
WO2009015981A3 (en) | Treatment of pediatric tumors | |
WO2009021943A3 (en) | Novel preparation process | |
WO2008155619A3 (en) | Preparation of optically-active cyclic amino acids |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 08762886 Country of ref document: EP Kind code of ref document: A2 |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 08762886 Country of ref document: EP Kind code of ref document: A2 |